Fig. 4From: The prevalence, risk factors, and prognostic value of venous thromboembolism in ovarian cancer patients receiving chemotherapy: a systematic review and meta-analysisForest plot for prevalence of venous thromboembolism (VTE) in ovarian cancer patients receiving adjuvant chemotherapy (a) and neoadjuvant chemotherapy (b)Back to article page